On 30 September 2025, Evonik Operations GmbH submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).] for a Union authorisation of the same biocidal product, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘OXTERIL® 350 VHP’, of product-types 2 and 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-RG110491-49 in the Register for Biocidal Products. The application referred to the biocidal product family ‘Evonik’s Hydrogen Peroxide Product Family’ authorised by Commission Implementing Regulation (EU) 2023/2183 [Commission Implementing Regulation (EU) 2023/2183 of 18 October 2023 granting a Union authorisation for the biocidal product family Evonik’s Hydrogen Peroxide Product Family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council. (OJ L, 2023/2183, 19.10.2023, ELI: http://data.europa.eu/eli/reg_impl/2023/2183/oj).], with authorisation number EU-0028964-0000.
Recital 1, Regulation (EU) 2026/2042
In forcesince 11 Sep 2026